350 related articles for article (PubMed ID: 21735169)
1. Angiogenesis and multiple myeloma.
Giuliani N; Storti P; Bolzoni M; Palma BD; Bonomini S
Cancer Microenviron; 2011 Dec; 4(3):325-37. PubMed ID: 21735169
[TBL] [Abstract][Full Text] [Related]
2. HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients.
Storti P; Donofrio G; Colla S; Airoldi I; Bolzoni M; Agnelli L; Abeltino M; Todoerti K; Lazzaretti M; Mancini C; Ribatti D; Bonomini S; Franceschi V; Pistoia V; Lisignoli G; Pedrazzini A; Cavicchi O; Neri A; Rizzoli V; Giuliani N
Leukemia; 2011 Mar; 25(3):527-37. PubMed ID: 21183939
[TBL] [Abstract][Full Text] [Related]
3. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.
Colla S; Tagliaferri S; Morandi F; Lunghi P; Donofrio G; Martorana D; Mancini C; Lazzaretti M; Mazzera L; Ravanetti L; Bonomini S; Ferrari L; Miranda C; Ladetto M; Neri TM; Neri A; Greco A; Mangoni M; Bonati A; Rizzoli V; Giuliani N
Blood; 2007 Dec; 110(13):4464-75. PubMed ID: 17848618
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow angiogenesis and progression in multiple myeloma.
Ria R; Reale A; De Luisi A; Ferrucci A; Moschetta M; Vacca A
Am J Blood Res; 2011; 1(1):76-89. PubMed ID: 22432068
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic switch in multiple myeloma.
Giuliani N; Colla S; Rizzoli V
Hematology; 2004; 9(5-6):377-81. PubMed ID: 15763977
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in multiple myeloma.
Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.
Martin SK; Diamond P; Williams SA; To LB; Peet DJ; Fujii N; Gronthos S; Harris AL; Zannettino AC
Haematologica; 2010 May; 95(5):776-84. PubMed ID: 20015878
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.
Storti P; Bolzoni M; Donofrio G; Airoldi I; Guasco D; Toscani D; Martella E; Lazzaretti M; Mancini C; Agnelli L; Patrene K; Maïga S; Franceschi V; Colla S; Anderson J; Neri A; Amiot M; Aversa F; Roodman GD; Giuliani N
Leukemia; 2013 Aug; 27(8):1697-706. PubMed ID: 23344526
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.
Kumar S; Witzig TE; Timm M; Haug J; Wellik L; Kimlinger TK; Greipp PR; Rajkumar SV
Blood; 2004 Aug; 104(4):1159-65. PubMed ID: 15130943
[TBL] [Abstract][Full Text] [Related]
10. Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.
Marchica V; Toscani D; Corcione A; Bolzoni M; Storti P; Vescovini R; Ferretti E; Dalla Palma B; Vicario E; Accardi F; Mancini C; Martella E; Ribatti D; Vacca A; Pistoia V; Giuliani N
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30845779
[TBL] [Abstract][Full Text] [Related]
11. Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma.
Pacini S; Montali M; Mazziotta F; Schifone CP; Macchia L; Carnicelli V; Panvini FM; Barachini S; Notarfranchi L; Previti GB; Buda G; Petrini M
Oncotarget; 2019 Nov; 10(63):6781-6790. PubMed ID: 31827721
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors and modulators of angiogenesis in multiple myeloma.
Ferrarini M; Ferrero E
Curr Med Chem; 2011; 18(34):5185-95. PubMed ID: 22087819
[TBL] [Abstract][Full Text] [Related]
13. HIF-2α-ILK Is Involved in Mesenchymal Stromal Cell Angiogenesis in Multiple Myeloma Under Hypoxic Conditions.
Zhang X; Xu Y; Liu H; Zhao P; Chen Y; Yue Z; Zhang Z; Wang X
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764473. PubMed ID: 29656700
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible factor-1 alpha and multiple myeloma.
Bhaskar A; Tiwary BN
Int J Adv Res (Indore); 2016 Jan; 4(1):706-715. PubMed ID: 26900575
[TBL] [Abstract][Full Text] [Related]
15. Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells.
Palano MT; Giannandrea D; Platonova N; Gaudenzi G; Falleni M; Tosi D; Lesma E; Citro V; Colombo M; Saltarella I; Ria R; Amodio N; Taiana E; Neri A; Vitale G; Chiaramonte R
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932949
[TBL] [Abstract][Full Text] [Related]
16. Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma.
Martin SK; Dewar AL; Farrugia AN; Horvath N; Gronthos S; To LB; Zannettino AC
Clin Cancer Res; 2006 Dec; 12(23):6973-7. PubMed ID: 17145816
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma.
Russignan A; Dal Collo G; Bagnato A; Tamassia N; Bugatti M; Belleri M; Lorenzi L; Borsi E; Bazzoni R; Gottardi M; Terragna C; Vermi W; Giacomini A; Presta M; Cassatella MA; Krampera M; Tecchio C
Front Oncol; 2020; 10():600025. PubMed ID: 33489901
[TBL] [Abstract][Full Text] [Related]
18. Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.
Calcinotto A; Ponzoni M; Ria R; Grioni M; Cattaneo E; Villa I; Sabrina Bertilaccio MT; Chesi M; Rubinacci A; Tonon G; Bergsagel PL; Vacca A; Bellone M
Oncoimmunology; 2015 Jun; 4(6):e1008850. PubMed ID: 26155424
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.
Vacca A; Ribatti D; Presta M; Minischetti M; Iurlaro M; Ria R; Albini A; Bussolino F; Dammacco F
Blood; 1999 May; 93(9):3064-73. PubMed ID: 10216103
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in multiple myeloma.
Vacca A; Ria R; Reale A; Ribatti D
Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
